Global Psoriasis Treatment Market Is Expected To Reach US$
12.8 Bn By 2025 – Credence Research
According to the latest market report published by Credence Research, Inc. “Psoriasis Treatment
Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global Psoriasis
Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by
2025, expanding at a CAGR of 5.4% from 2017 to 2025.
Browse the full report Psoriasis Treatment Market – Growth, Future Prospects and
Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/psoriasistreatment-market
Market Insights
Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great
negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation
and to stop the skin cells from growing quickly. Psoriasis treatment market is rapidly growing due
to factors such as growing prevalence in some countries, significant unmet needs, promising
pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of
study, global psoriasis treatment market is segmented on the basis of drug class such as TNF
Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed
that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its
long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is
categorized on the basis of route of administration such as topical, oral and parenteral therapeutic
drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more
effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would
show significant growth during forecast period because newly approved biologics are generally
preferred in moderate to severe psoriasis. Psoriasis treatment market is currently dominated by
North America, factors such as higher cost of therapy, higher number of psoriasis patient,
government reimbursement policies fueling the growth of psoriasis treatment market in North
America.
Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469
Market Competition Assessment:
The psoriasis treatment market is observed to be highly competitive and comprises large number
of players. However, the market is currently dominated by few players such as AbbVie Inc.,
Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company,
Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel
Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.
Key Market Movements:



Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher
treatment compliance and favorable reimbursement policies in some countries are driving
the market growth of psoriasis treatment worldwide.
Due to the high unmet needs, vendors in the market are focusing in development of ideal
treatment, promising pipeline molecule, rising access for the treatment medication in some
developing countries, increase in incidence of psoriasis and skin disorders would fuel the
growth of psoriasis treatment market during forecast period.
However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects
associated with the use of medication which would negatively impact the growth of
psoriasis treatment market.
Request Free Sample of This Report @ http://www.credenceresearch.com/samplerequest/58469
Table of Content
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
Chapter 2 Executive Summary
2.1 Global Psoriasis Treatment Market Snapshot
2.2 Global Psoriasis Treatment Market, Drug Class
2.3 Global Psoriasis Treatment Market, Type
2.4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Psoriasis Treatment Market Analysis
3.1 Global Psoriasis Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis in Psoriasis Treatment Market
3.4 Global Epidemiology Data for Psoriasis
3.5 Comparative study of Psoriasis Therapeutics
3.5.1 Tremfya (Guselkumab)
3.5.2 Siliq (Brodalumab)
3.5.3 Taltz (Ixekizumab)
3.6 Attractive Investment Proposition
3.7 Competitive Landscape of Key Players in Psoriasis Treatment Market
Chapter 4 Global Psoriasis Treatment Market, by Drug Class
4.1 Overview
4.2 Top 3 Countries
4.3 TNF Inhibitors
4.4 Vitamin D Analogues
4.5 Interleukin Blockers
4.6 Topical Corticosteroids
4.7 Other
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
Chapter 5 Global Psoriasis Treatment Market, by Type
5.1 Overview
5.2 Top 3 Countries
5.3 Plaque psoriasis
5.4 Guttate psoriasis
5.5 Flexural or inverse psoriasis
5.6 Psoriatic arthritis
5.7 Other
Chapter 6 Global Psoriasis Treatment Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.2.2 North America Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.2.3 North America Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.3.2 Europe Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.3.3 Europe Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.4.1 Asia Pacific Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.4.2 Asia Pacific Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.4.1 Asia Pacific Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.5.2 Latin America Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.5.3 Latin America Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Psoriasis Treatment Market, by Drug Class, 2015- 2025 (US$)
6.6.2 Middle East and Africa Psoriasis Treatment Market, by Type, 2015- 2025 (US$)
6.6.3 Middle East and Africa Psoriasis Treatment Market, by Country, 2015- 2025 (US$)
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
Chapter 7 Company Profiles
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 AstraZeneca
7.4 Biogen
7.5 Boehringer Ingelheim
7.6 Celgene
7.7 Eli Lilly and Company
7.8 Johnson & Johnson
7.9 LEO Pharma A/S
7.10 Merck & Co., Inc.
7.11 Novartis AG
7.12 Pfizer, Inc.
7.13 Stiefel Laboratories Inc. (GlaxoSmithKline plc)
7.14 Sun Pharmaceutical Industries
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
List Of Table
TABLE 1 Market Positioning of Key Players in Global Psoriasis Treatment Market
TABLE 2 Global Psoriasis Treatment Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Psoriasis Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Psoriasis Treatment Market, by Type, 2015 – 2025 (US$ Bn)
TABLE 5 Top 3 Countries in Global Psoriasis Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Psoriasis Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 7 North America Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 North America Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 9 North America Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 10 Europe Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 11 Europe Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 12 Europe Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Asia Pacific Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Asia Pacific Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 15 Asia Pacific Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 16 Latin America Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 17 Latin America Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 18 Latin America Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 19 Middle East and Africa Psoriasis Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 20 Middle East and Africa Psoriasis Treatment Market, by Type, 2015-2025 (US$ Bn)
TABLE 21 Middle East and Africa Psoriasis Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 22 AbbVie Inc.: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 23 Amgen Inc.: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 24 AstraZeneca: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 25 Biogen: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 26 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 27 Celgene: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
TABLE 28 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 29 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 30 LEO Pharma A/S: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 31 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 32 Novartis AG: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 33 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product
Position/Portfolio; News Coverage)
TABLE 34 Stiefel Laboratories Inc. (GlaxoSmithKline plc): Company Snapshot (Business Description;
Financial Information; Product Position/Portfolio; News Coverage)
TABLE 35 Sun Pharmaceutical Industries: Company Snapshot (Business Description; Financial Information;
Product Position/Portfolio; News Coverage)
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
List Of Figures
FIG. 1 Psoriasis Treatment Market: Research Methodology
FIG. 2 Global Psoriasis Treatment Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Psoriasis Treatment Market, by Type, 2016 (US$ Bn)
FIG. 4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition: Global Psoriasis Treatment Market, by Geography, 2016
FIG. 6 Global TNF Inhibitors Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Vitamin D Analogues Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Interleukin Blockers Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Topical Corticosteroids Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Other Psoriasis Medication Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Plaque Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 12 Global Guttate Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 13 Global Flexural or Inverse Psoriasis Market, 2015 – 2025 (US$ Bn)
FIG. 14 Global Psoriatic Arthritis Market, 2015 – 2025 (US$ Bn)
FIG. 15 Global Other Types of Psoriasis Market, 2015 – 2025 (US$ Bn)
Access This Full Report @ http://www.credenceresearch.com/report/psoriasis-treatment-market
About Credence Research:
Credence Research is a worldwide market research and counseling firm that serves driving organizations,
governments, non legislative associations, and not-for-benefits. We offer our customers some assistance
with making enduring enhancements to their execution and understand their most imperative objectives.
Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
For More Information, Visit: http://www.credenceresearch.com/
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith,
Designation: Global Sales Manager
Phone: +1-800-361-8290 FREE
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103
E-mail: [email protected]